Total Payments
$272,303
2024 Payments
$1,914
Companies
25
Transactions
114
Medicare Patients
3,161
Medicare Billing
$296,429
Payment Breakdown by Category
Research$242,396 (89.0%)
Consulting$23,452 (8.6%)
Food & Beverage$3,269 (1.2%)
Travel$3,185 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $242,396 | 27 | 89.0% |
| Consulting Fee | $23,452 | 7 | 8.6% |
| Food and Beverage | $3,269 | 74 | 1.2% |
| Travel and Lodging | $3,185 | 6 | 1.2% |
Payments by Type
Research
$242,396
27 transactions
General
$29,907
87 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PolarityTE, Inc. | $147,000 | 15 | $0 (2021) |
| Integra LifeSciences Corporation | $93,876 | 16 | $0 (2022) |
| HARTMANN USA, INC. | $17,612 | 6 | $0 (2022) |
| Ipsen Innovation | $6,235 | 10 | $0 (2018) |
| ConvaTec Inc. | $2,625 | 11 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $1,759 | 3 | $0 (2024) |
| KCI USA, Inc | $595.44 | 4 | $0 (2019) |
| Organogenesis Inc. | $560.93 | 18 | $0 (2019) |
| TissueTech, Inc. | $558.12 | 3 | $0 (2020) |
| Acera Surgical, Inc. | $468.77 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,914 | 4 | Lexicon Pharmaceuticals, Inc. ($1,759) |
| 2023 | $2,043 | 5 | ConvaTec Inc. ($1,926) |
| 2022 | $18,493 | 12 | HARTMANN USA, INC. ($17,517) |
| 2021 | $8,878 | 11 | PolarityTE, Inc. ($8,500) |
| 2020 | $222,951 | 25 | PolarityTE, Inc. ($128,500) |
| 2019 | $11,477 | 36 | PolarityTE, Inc. ($10,000) |
| 2018 | $5,599 | 8 | Ipsen Innovation ($5,400) |
| 2017 | $948.49 | 13 | Ipsen Innovation ($834.99) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | Lexicon Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $1,133.71 | Research |
| Study: LX9211 | ||||||
| 04/25/2024 | Lexicon Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $484.12 | Research |
| Study: LX9211 | ||||||
| 04/25/2024 | Lexicon Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $141.45 | Research |
| Study: LX9211 | ||||||
| 02/28/2024 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $154.48 | General |
| Category: Wound Care | ||||||
| 11/03/2023 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $95.35 | General |
| Category: Wound Care | ||||||
| 09/10/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $162.88 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/09/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Travel and Lodging | Cash or cash equivalent | $1,702.98 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 09/09/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 05/10/2023 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Wound Care | ||||||
| 10/15/2022 | PolyNovo North America LLC | — | Food and Beverage | Cash or cash equivalent | $99.39 | General |
| 10/15/2022 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $83.09 | General |
| Category: Recon-Skin and Wound | ||||||
| 10/14/2022 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: Wound Care | ||||||
| 10/14/2022 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $78.47 | General |
| Category: Recon-Skin and Wound | ||||||
| 10/14/2022 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $60.97 | General |
| Category: Wound Care | ||||||
| 09/29/2022 | HARTMANN USA, INC. | Zetuvit Plus (Device) | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| Category: Wound Care | ||||||
| 08/11/2022 | ConvaTec Inc. | AQUACEL AG+ (Device) | Food and Beverage | In-kind items and services | $88.46 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 08/01/2022 | HARTMANN USA, INC. | Zetuvit Plus (Device) | Consulting Fee | Cash or cash equivalent | $12,950.00 | General |
| Category: Wound Care | ||||||
| 06/01/2022 | ConvaTec Inc. | AQUACEL AG+ (Device) | Food and Beverage | In-kind items and services | $111.99 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 05/13/2022 | ConvaTec Inc. | CONVATEC INC. (Medical Supply) | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 04/21/2022 | HARTMANN USA, INC. | Zetuvit Plus (Device) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Wound Care | ||||||
| 03/29/2022 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $6.99 | General |
| 12/16/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $120.20 | General |
| Category: Oncology | ||||||
| 12/02/2021 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Wound Care | ||||||
| 11/17/2021 | HARTMANN USA, INC. | Zetuvit Plus (Device) | Food and Beverage | Cash or cash equivalent | $37.88 | General |
| Category: Wound Care | ||||||
| 10/27/2021 | ConvaTec Inc. | AQUACEL Ag Advantage Surgical (Device) | Food and Beverage | Cash or cash equivalent | $98.67 | General |
| Category: Advanced Wound Care | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| T-PMXDFU | Integra LifeSciences Corporation | $86,212 | 5 |
| RCT DFU | PolarityTE, Inc. | $77,000 | 10 |
| RCT VLU | PolarityTE, Inc. | $70,000 | 5 |
| T-PMXDFU-01 | Integra LifeSciences Corporation | $7,425 | 4 |
| LX9211 | Lexicon Pharmaceuticals, Inc. | $1,759 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 561 | 861 | $207,165 | $56,059 |
| 2022 | 10 | 823 | 1,354 | $286,219 | $76,592 |
| 2021 | 15 | 987 | 1,484 | $350,264 | $92,087 |
| 2020 | 11 | 790 | 1,228 | $286,508 | $71,690 |
Total Patients
3,161
Total Services
4,927
Medicare Billing
$296,429
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 395 | $98,138 | $28,786 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 191 | 191 | $58,293 | $16,791 | 28.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 22 | 33 | $17,188 | $3,537 | 20.6% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 20 | 32 | $11,237 | $2,369 | 21.1% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2023 | 16 | 17 | $7,827 | $1,656 | 21.2% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 15 | 15 | $5,055 | $1,120 | 22.2% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 13 | 15 | $3,317 | $587.50 | 17.7% |
| 64455 | Injection of anesthetic and/or steroid drug into foot nerve | Office | 2023 | 12 | 13 | $2,671 | $572.95 | 21.5% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 12 | 14 | $2,408 | $535.04 | 22.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 136 | $1,032 | $105.11 | 10.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 259 | 489 | $121,493 | $35,079 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 334 | 334 | $101,868 | $28,346 | 27.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 28 | 46 | $23,838 | $4,742 | 19.9% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 20 | 25 | $8,737 | $2,211 | 25.3% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 22 | 24 | $7,999 | $1,573 | 19.7% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 30 | 30 | $6,619 | $1,420 | 21.5% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 35 | 37 | $6,363 | $1,362 | 21.4% |
| 64455 | Injection of anesthetic and/or steroid drug into foot nerve | Office | 2022 | 24 | 25 | $4,922 | $992.99 | 20.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,860 | $588.83 | 31.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 59 | 332 | $2,520 | $275.48 | 10.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 249 | 374 | $92,424 | $28,372 | 30.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 299 | 299 | $90,366 | $26,269 | 29.1% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Office | 2021 | 44 | 97 | $49,361 | $10,832 | 21.9% |
| 97597 | Removal of tissue from wounds per session, first 20 sq cms or less | Office | 2021 | 31 | 63 | $21,257 | $4,613 | 21.7% |
| 11721 | Removal of tissue from 6 or more finger or toe nails | Office | 2021 | 98 | 124 | $21,126 | $4,439 | 21.0% |
About Dr. Dean Vayser, D.P.M
Dr. Dean Vayser, D.P.M is a Podiatrist healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013961598.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dean Vayser, D.P.M has received a total of $272,303 in payments from pharmaceutical and medical device companies, with $1,914 received in 2024. These payments were reported across 114 transactions from 25 companies. The most common payment nature is "" ($242,396).
As a Medicare-enrolled provider, Vayser has provided services to 3,161 Medicare beneficiaries, totaling 4,927 services with total Medicare billing of $296,429. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Podiatrist
- Location La Jolla, CA
- Active Since 05/20/2006
- Last Updated 06/29/2009
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1013961598
Products in Payments
- SkinTE (Biological) $138,500
- PRIMATRIX (Device) $93,637
- Zetuvit Plus (Device) $17,577
- Dysport (Drug) $6,235
- INNOVAMATRIX AC (Device) $1,926
- Prokera (Device) $558.12
- Apligraf (Device) $512.56
- Restrata Wound Matrix (Device) $468.77
- CONVATEC INC. (Medical Supply) $325.00
- AQUACEL AG+ (Device) $200.45
- Integra (Device) $161.56
- LIBTAYO (Biological) $120.20
- Ankle Fix Plates and Instruments (Device) $117.45
- Bone Healing Product Portfolio (Device) $116.57
- AQUACEL Ag Advantage Surgical (Device) $98.67
- OMNIGRAFT (Device) $77.32
- KERRAMAX CARE (Device) $72.38
- Qutenza (Drug) $60.23
- TheraSkin (Biological) $40.80
- ADAPTIC (Device) $37.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.